The semaglutide pen injector: what it does, how to use it, and what to expect

Your first injection: the moment most people dread (and then wonder why they did)

Picture the scene: the pen arrives in its box, cold from transit, and you're sitting at the kitchen table reading the instructions for the first time. One thing our prescribers hear from patients is the assumption that a weekly injection must be complicated or painful. It rarely is either. The Wegovy pen has a covered needle that retracts automatically after injection, so you never see it. The needle itself is very fine and very short, designed specifically for subcutaneous use just below the surface of the skin rather than into muscle.

Before you start, let the pen reach room temperature for around 30 minutes, injecting cold medicine straight from the fridge is one of the most common causes of discomfort at the site. Choose a spot on your abdomen (at least a couple of inches from the navel), the front of your thigh, or your upper arm. Clean the area with an alcohol swab and let it dry fully. Remove the pen cap, press the pen flat against the skin, and press the button until you hear a click and the injection indicator confirms the dose has been delivered. Hold for ten seconds before removing. That is broadly it.

Rotate your injection site each week. Using the same spot repeatedly can cause a small area of hardened tissue under the skin (lipohypertrophy), which absorbs medicine less predictably. A simple mental map (left abdomen one week, right thigh the next) makes rotation effortless. For a more detailed step-by-step, the guide to injecting semaglutide walks through each stage carefully.

What the titration schedule means for the pen you receive

Wegovy is prescribed at progressively higher strengths over several months. Treatment begins at 0.25 mg, moving through 0.5 mg, 1.0 mg and 1.7 mg before reaching the 2.4 mg maintenance dose, with roughly four weeks at each level. The MHRA also approved a higher 7.2 mg maintenance dose in early 2026, supplied via a dedicated semaglutide autoinjector confirmed in April of that year.

Each pen contains four pre-set doses (one per week) at a single strength. When your prescriber moves you to the next level, you receive a new pen at that strength; there is no manual adjustment on the device itself. This matters practically: if you want to understand exactly how the semaglutide pen is designed and calibrated, that page covers the device in detail. Never attempt to take more than one dose per pen in a single week, and never try to transfer medicine between pens.

If you miss a dose, the advice from the NHS semaglutide guidance is to take it as soon as you remember, provided your next scheduled dose is at least two days away. If the gap is shorter, skip the missed dose and continue on your usual day. Adjusting timing or dose is always a conversation with your prescriber, not a self-managed decision. Our team at our clinical team reviews every patient's progress before approving a dose increase.

Side effects linked to the pen and the medicine itself

Most side effects from semaglutide are gastrointestinal rather than related to the injection device. Nausea is the most commonly reported, especially in the first few weeks after a dose increase. Loose stools, constipation, indigestion and fatigue are also documented. These typically ease as the body adjusts, and the slow titration schedule exists precisely to reduce their intensity.

At the injection site itself, you may notice brief redness, mild bruising or a small raised area immediately afterwards. This usually resolves within a day or two and is distinct from any reaction to the medicine. Rotating your injection site, as described above, is the best prevention.

One misconception worth gently setting aside: a number of people assume that injecting in a different body area will produce a different speed of effect. The three licensed sites (abdomen, thigh, upper arm) are all appropriate and absorption is not meaningfully different between them. Pick whichever is most comfortable and rotate within that.

The MHRA monitors new medicines closely. Wegovy carries a Black Triangle (▼) designation, meaning that healthcare professionals and patients are encouraged to report any suspected side effects via the Yellow Card scheme. Serious symptoms (particularly severe and persistent stomach pain that radiates to the back) need prompt medical assessment; do not wait for your next appointment.

The pen, the prescription and what comes next

The Wegovy pen injector is a prescription-only device containing a prescription-only medicine. In the UK, you cannot lawfully obtain it without a clinical assessment by a registered prescriber. That assessment covers your BMI, any weight-related health conditions, your current medicines and your medical history, among other factors. The pen itself is only one piece; the clinical oversight around it is what makes the treatment safe.

If you are exploring the cost side of private treatment, the cost context for Wegovy in the UK explains what drives pricing and what a legitimate price should include. At nume, every order goes through a same-day clinical review by a GPhC-registered prescriber, a real person reading your consultation, not an automated pass. If approved, treatment is dispatched the same day for free next-working-day delivery via DPD.

Used needles and empty pens are classified as sharps. A sharps container is the safe and legally correct way to dispose of them; your local council or pharmacy will advise on collection. Ready to find out whether Wegovy is clinically appropriate for you? Check your eligibility with a free consultation and our prescribers will review your answers the same day.